{"id":6573,"date":"2019-02-05T08:29:30","date_gmt":"2019-02-05T13:29:30","guid":{"rendered":"https:\/\/www.stockcalc.com\/blog\/BrianD\/?p=6573"},"modified":"2019-02-05T08:29:30","modified_gmt":"2019-02-05T13:29:30","slug":"cidara-therapeutics-cdtxnas-and-scpharmaceuticals-scphnas-trading-at-less-than-cash-value","status":"publish","type":"post","link":"https:\/\/www.stockcalc.com\/blog\/BrianD\/2019\/02\/05\/cidara-therapeutics-cdtxnas-and-scpharmaceuticals-scphnas-trading-at-less-than-cash-value\/","title":{"rendered":"Cidara Therapeutics (CDTX:NAS) and scPharmaceuticals (SCPH:NAS) Trading at Less than Cash Value"},"content":{"rendered":"

Stockcalc – Free Trial<\/h4>\n

Have a free look inside the StockCalc website at www.stockcalc.com<\/a><\/p>\n

\n
\n<\/hr>\n

I have used the analysis tools on the website stockcalc.com<\/a> to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com\/TopPicks.aspx<\/a>.<\/p>\n

Trading at Less than Cash Value<\/h4>\n

Today we are looking at companies trading at less than cash value<\/strong> meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.<\/p>\n

What this Means…<\/h5>\n

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P\/E greater than 0 and are worth exploring in more detail.<\/p>\n

Today’s Data on NASDAQ<\/h4>\n

Today’s data is for companies listed on the NASDAQ<\/strong>.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Symbol<\/th>\nName<\/th>\nClose Price<\/th>\nShares Outstanding<\/th>\nP\/E<\/th>\nP\/B<\/th>\nCash per Share<\/th>\nNet Cash per Share<\/th>\n<\/tr>\n
LEXEA<\/td>\nLiberty Expedia Holdings Inc<\/td>\n42.300000<\/td>\n57315762<\/td>\nNone<\/td>\n0.9932<\/td>\n52.55<\/td>\n-22.37<\/td>\n<\/tr>\n
LEXEB<\/td>\nLiberty Expedia Holdings Inc<\/td>\n40.170000<\/td>\n57315762<\/td>\nNone<\/td>\n0.9432<\/td>\n52.55<\/td>\n-22.37<\/td>\n<\/tr>\n
SOHU<\/td>\nSohu.com Ltd<\/td>\n21.460000<\/td>\n38916788<\/td>\nNone<\/td>\n1.2571<\/td>\n29.71<\/td>\n23.98<\/td>\n<\/tr>\n
LJPC<\/td>\nLa Jolla Pharmaceutical Co<\/td>\n6.180000<\/td>\n26233631<\/td>\nNone<\/td>\n2.3719<\/td>\n7.79<\/td>\n0.16<\/td>\n<\/tr>\n
CAAS<\/td>\nChina Automotive Systems Inc<\/td>\n2.810000<\/td>\n31644004<\/td>\nNone<\/td>\n0.3083<\/td>\n3.03<\/td>\n0.78<\/td>\n<\/tr>\n
CDTX<\/td>\nCidara Therapeutics Inc<\/td>\n2.840000<\/td>\n27751431<\/td>\nNone<\/td>\n1.1270<\/td>\n3.02<\/td>\n2.66<\/td>\n<\/tr>\n
SCPH<\/td>\nscPharmaceuticals Inc<\/td>\n4.180000<\/td>\n18569289<\/td>\nNone<\/td>\n0.9308<\/td>\n5.13<\/td>\n4.61<\/td>\n<\/tr>\n
IDRA<\/td>\nIdera Pharmaceuticals Inc<\/td>\n2.570000<\/td>\n27181436<\/td>\nNone<\/td>\n0.9331<\/td>\n3.03<\/td>\n3.95<\/td>\n<\/tr>\n
ETTX<\/td>\nEntasis Therapeutics Holdings Inc<\/td>\n4.900000<\/td>\n13099735<\/td>\nNone<\/td>\n0.7094<\/td>\n7.18<\/td>\nNone<\/td>\n<\/tr>\n
SNNA<\/td>\nSienna Biopharmaceuticals Inc<\/td>\n2.830000<\/td>\n21140101<\/td>\n2.2095<\/td>\n1.3315<\/td>\n3.03<\/td>\n1.61<\/td>\n<\/tr>\n
AQXP<\/td>\nAquinox Pharmaceuticals Inc<\/td>\n2.390000<\/td>\n23537368<\/td>\nNone<\/td>\n0.7332<\/td>\n3.68<\/td>\n3.68<\/td>\n<\/tr>\n
VVUS<\/td>\nVIVUS Inc<\/td>\n4.930000<\/td>\n10629923<\/td>\nNone<\/td>\nNone<\/td>\n5.46<\/td>\n-22.78<\/td>\n<\/tr>\n
ARAV<\/td>\nAravive Inc<\/td>\n4.200000<\/td>\n11182025<\/td>\n4.0777<\/td>\n0.7371<\/td>\n5.60<\/td>\n5.41<\/td>\n<\/tr>\n
ASNS<\/td>\nArsanis Inc<\/td>\n2.730000<\/td>\n14315410<\/td>\nNone<\/td>\n1.4009<\/td>\n2.85<\/td>\n2.10<\/td>\n<\/tr>\n
GIGM<\/td>\nGigaMedia Ltd<\/td>\n2.790000<\/td>\n11052235<\/td>\nNone<\/td>\n0.5280<\/td>\n5.42<\/td>\n5.77<\/td>\n<\/tr>\n
TRMT<\/td>\nTremont Mortgage Trust<\/td>\n8.680000<\/td>\n3179118<\/td>\nNone<\/td>\n0.4845<\/td>\n9.47<\/td>\n-0.43<\/td>\n<\/tr>\n
BIQI<\/td>\nRenmin Tianli Group Inc<\/td>\n2.810000<\/td>\n8033745<\/td>\n19.5000<\/td>\n0.2583<\/td>\n7.64<\/td>\n7.39<\/td>\n<\/tr>\n
GEVO<\/td>\nGevo Inc<\/td>\n2.540000<\/td>\n8640433<\/td>\nNone<\/td>\n0.2354<\/td>\n4.43<\/td>\n2.95<\/td>\n<\/tr>\n
ONTX<\/td>\nOnconova Therapeutics Inc<\/td>\n3.360000<\/td>\n5674220<\/td>\nNone<\/td>\n1.7556<\/td>\n3.94<\/td>\nNone<\/td>\n<\/tr>\n
SAEX<\/td>\nSAExploration Holdings Inc<\/td>\n4.120000<\/td>\n2917160<\/td>\nNone<\/td>\n0.3679<\/td>\n6.97<\/td>\n-25.35<\/td>\n<\/tr>\n
RLM<\/td>\nRealm Therapeutics PLC<\/td>\n2.580000<\/td>\n4662476<\/td>\nNone<\/td>\n0.4954<\/td>\n3.48<\/td>\n2.74<\/td>\n<\/tr>\n
MDGS<\/td>\nMedigus Ltd<\/td>\n2.640000<\/td>\n3796602<\/td>\nNone<\/td>\n1.1324<\/td>\n3.14<\/td>\nNone<\/td>\n<\/tr>\n
KBSF<\/td>\nKBS Fashion Group Ltd<\/td>\n3.710000<\/td>\n2228497<\/td>\nNone<\/td>\n0.1205<\/td>\n9.07<\/td>\n8.58<\/td>\n<\/tr>\n
DFFN<\/td>\nDiffusion Pharmaceuticals Inc<\/td>\n2.250000<\/td>\n3376245<\/td>\n1.0484<\/td>\n0.3633<\/td>\n3.26<\/td>\n4.64<\/td>\n<\/tr>\n
CHFS<\/td>\nCHF Solutions Inc<\/td>\n7.470000<\/td>\n512460<\/td>\nNone<\/td>\n0.3966<\/td>\n16.04<\/td>\n2.58<\/td>\n<\/tr>\n<\/table>\n

Let’s look at a few companies…<\/h4>\n

Lets look at a couple of the companies on this list to get a better understanding of them.<\/p>\n

CDTX:NAS Cidara Therapeutics<\/h6>\n

http:\/\/www.cidara.com<\/a>
\nCidara Therapeutics has 61 employees and is headquartered in United States.
\nCidara Therapeutics Inc mainly develops anti-infective drugs in the United States. It attends to serious fungal infections through its drug candidates and proprietary immunotherapy technology platform, Cloudbreak.<\/p>\n

SCPH:NAS scPharmaceuticals<\/h6>\n

http:\/\/www.scpharmaceuticals.com<\/a>
\nscPharmaceuticals has 27 employees and is headquartered in United States.
\nscPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on proven pharmaceutical products in the cardiovascular and infectious disease therapeutic areas.<\/p>\n

Free Valuation<\/h4>\n

Run a valuation on any of the companies listed above at www.stockcalc.com\/valureport.aspx<\/a> or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports<\/a>.<\/p>\n

The content presented here is in part from the website stockcalc.com<\/a> and is provided on an as is<\/strong> or as available<\/strong> basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.<\/em><\/p>\n

<\/div>\n
\n

Wait! We want you to try StockCalc for<\/span><\/h2>\n

5 Free Days <\/h1>\n

Yes, I want to find out what my stocks are worth<\/span><\/a>
\n No, I don’t want to know the value of my stocks<\/span><\/a>\n <\/div>\n